Prices as of 2026/10/30 close
Company comparison · Diabetes Care Devices
Nipro is the bigger company, with revenue of ¥660.5B — 1.8x PHC's ¥364.4B.
PHC earns more on each yen of sales, with an operating margin of 6.2% — 0.5 points above Nipro (5.7%).
Revenue growth in the latest results: Nipro +2.5%, PHC +0.8%. For next year, PHC guides for the fastest operating profit growth (+19.0%).
PHC pays more on average — ¥9.83M against ¥6.81M at Nipro.
Over the past year the shares moved PHC +37.1%, Nipro −9.0%.
Head-to-head wins16 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Nipro aheadNipro 3 : PHC 0
Revenue: Nipro ¥660.5B / PHC ¥364.4B
ProfitabilityInvestors
EvenNipro 2 : PHC 2
Operating margin: Nipro 5.7% / PHC 6.2%
GrowthInvestors
Nipro aheadNipro 3 : PHC 1
Revenue growth (YoY): Nipro +2.5% / PHC +0.8%
Stock & balance sheetInvestors
PHC aheadNipro 0 : PHC 3
Share price, 1 year: Nipro −9.0% / PHC +37.1%
Pay & workforceJob seekers
PHC aheadNipro 0 : PHC 2
Average salary: Nipro ¥6.81M / PHC ¥9.83M
| Metric | Nipro | PHC | Gap |
|---|---|---|---|
| Revenue | ◎¥660.5B | ¥364.4B | 1.8x |
| Operating profit | ◎¥37.6B | ¥22.7B | 1.7x |
| Net income | ◎¥13.5B | ¥492M | 27.4x |
| Metric | Nipro | PHC | Gap |
|---|---|---|---|
| Operating margin | 5.7% | ◎6.2% | 0.5pt |
| Net margin | ◎2.0% | 0.1% | 1.9pt |
| ROE | ◎5.1% | 0.3% | 4.8pt |
| Revenue per employee | ¥140M | ◎¥2.5B | 17.9x |
| Metric | Nipro | PHC | Gap |
|---|---|---|---|
| Revenue growth (YoY) | ◎+2.5% | +0.8% | 1.7pt |
| Operating profit growth (YoY) | ◎+41.5% | +0.5% | 41.0pt |
| Guidance: revenue growthnext FY plan | ◎+6.0% | −1.3% | 7.3pt |
| Guidance: op. profit growthnext FY plan | +6.3% | ◎+19.0% | 12.7pt |
| Metric | Nipro | PHC | Gap |
|---|---|---|---|
| Share price, 1 year | −9.0% | ◎+37.1% | 46.1pt |
| Share price, 3 months | −18.5% | ◎+27.9% | 46.4pt |
| P/E (trailing)lower = cheaper | 16.5x | — | |
| Equity ratio | 27.6% | ◎29.7% | 2.1pt |
| Share price (close) | ¥1,363 | ¥1,415 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Nipro | PHC | Gap |
|---|---|---|---|
| Average salary | ¥6.81M | ◎¥9.83M | ¥3.02M |
| Starting salary (monthly) | ¥265,500 | — | |
| Average tenure | 13.3 yrs | ◎17.5 yrs | 4.2 |
| Average age | 40.8 | 49.0 | 8.2 |
| Employees | 4,714 | 145 | 32.5x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥1,363-9.0% (1Y)
Nipro -9.0% over 1Y. Compared: PHC +37.1%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Nipro4 segments
PHC4 segments
AAverage annual salary from the securities filings: PHC ¥9.83M, Nipro ¥6.81M. PHC pays the most. Averages also depend on staff age and job mix, so check the average age too (Nipro 40.8, PHC 49.0).
ARevenue in the latest results: Nipro ¥660.5B, PHC ¥364.4B. Nipro is the bigger company, with revenue of ¥660.5B — 1.8x PHC's ¥364.4B.
AOperating margins: PHC 6.2%, Nipro 5.7%. PHC turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): PHC +37.1%, Nipro −9.0%. PHC has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
